Tid Tittel Kategori Vedlegg
13.03.2026
16:28
 EXACT Therapeutics AS - Minutes from extraordinary general meeting on 13 March 2026 -
1
03.03.2026
14:15
 EXACT Therapeutics - First patient dosed in Europe in Phase 2 trial in patients with locally advanced pancreatic cancer - -
27.02.2026
13:16
 EXACT Therapeutics AS: Notice of extraordinary general meeting -
1
27.02.2026
08:54
 EXACT Therapeutics AS: Warrants exercise - -
11.02.2026
08:00
 EXACT Therapeutics: Investor presentation for the global investor call regarding the ongoing warrants exercise program -
1
06.02.2026
08:30
 EXACT Therapeutics: Global investor call regarding the ongoing warrants exercise program - -
05.02.2026
13:19
 EXACT Therapeutics: Correction of final warrants exercise date - -
05.02.2026
09:17
 EXACT Therapeutics: Warrants exercise by leading shareholders and primary insiders INSIDEHANDEL INS
2
05.02.2026
08:30
 EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB INFORMASJON INF -
27.01.2026
08:00
 EXACT Therapeutics: Positive initial safety read-out from the Phase 2 ENACT trial in pancreatic cancer, triggering option to exercise warrants INFORMASJON INF -
08.01.2026
08:30
 EXACT Therapeutics’ Phase 2 trial in pancreatic cancer patients to be presented at the 2026 ASCO Gastrointestinal Cancers Symposium - -
25.11.2025
12:57
 EXACT Therapeutics to present company update -
1
24.11.2025
08:25
 EXACT Therapeutics AS: New option program and receipt of share options by primary insiders INSIDEHANDEL INS
1